摘要
回顾了近年来甲状腺良恶性结节评估的研究,重点介绍基因及分子标志物方面的研究进展,分析和评价了其临床应用的优缺点及应用前景。
This article reviewed the research on evaluating benign and malignant thyroid nodules in recent years, and particularly focused on the oncogens and molecular markers. Their advantages and disadvantages in clinical use and application prospective were reviewed and analyzed.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2013年第7期545-547,共3页
Chinese Journal of Endocrinology and Metabolism